BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2015
View Archived Issues
Reprogramming of delta and alpha cells associated with beta-cell independent insulin production
Read More
Amarantus BioScience reports data from LymPro Test
Read More
Garvan Institute spins off Solvanix
Read More
Milestone in Novogen's regenerative medicine program
Read More
Acorda Therapeutics provides overview on ongoing projects
Read More
Safety and dosing data presented for a novel gastric cancer vaccine
Read More
Ultragenyx Pharmaceuticals reviews pipeline
Read More
Alkermes presents overview of development pipeline at J.P. Morgan conference
Read More
Roche acquires Trophos to expand portfolio in neuromuscular disease
Read More
Alios BioPharma discloses new nuclosides for infections
Read More
LG Life Sciences patents novel FFA4 receptor antagonists
Read More
Genentech patent reports new EGFR T790M mutant inhibitors
Read More
New FPR2/ALX agonists designed by Actelion Pharmaceuticals
Read More
Scientists at Merck & Co. disclose novel NS5B inhibitors for HCV
Read More
Otezla receives approval in the E.U. for the treatment of psoriasis and psoriatic arthritis
Read More
Johnson & Johnson confirms formation of Ebola vaccine development consortia
Read More
NBI-77860 awarded U.S. orphan drug designation for congenital adrenal hyperplasia
Read More
Sanofi launches Allegra Dry Syrup 5% in Japan for allergic diseases
Read More
Antibe Therapeutics halts phase I ATB-345 trial due to safety concerns
Read More
Vect-Horus and Sanofi sign agreement for delivery of neurodegenerative disease therapy to brain
Read More
European Commission approves Ofev for idiopathic pulmonary fibrosis
Read More
Evotec and C4X Discovery collaborate to discover OX1 receptor inhibitors for addiction
Read More
Solasia and Meiji Seika sign Japanese license agreement for darinaparsin
Read More
